Reference to what was published in the news under 'Avigan® Approved for COVID-19 Treatment in Malaysia', Agility would like to announce that the Malaysian Ministry of Health's Drug Control Authority has approved Avigan® for use in treatment of COVID-19 patients.

Earlier this year, Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy's Laboratories signed an agreement for exclusive global production, distribution and commercialization of the drug with its developer, FujiFilm Toyama Chemical.

Agility cannot assess the financial impact at the moment.

Sincerely,

Investor Relations Team

Attachments

  • Original document
  • Permalink

Disclaimer

Agility - The Public Warehousing Company KSCP published this content on 09 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2020 02:20:03 UTC